Articles
Bridging the Gaps in Complex Patient Journeys by Enriching Data
Generating insights about patients on specialty therapies through data aggregation and integration can improve patient outcomes
As the number of specialty drugs expands in complex disease areas, such as autoimmune, multiple sclerosis, oncology, and respiratory illnesses, pharmaceutical companies have shown...
Articles
Maximising Tablet Production Through Essential Maintenance Measures
The growing demand for increased tablet quantities and the goal of reducing time to market is putting pressure on manufacturers to produce quality tablets in record time. This calls for the implementation of efficient procedures, quality equipment and an...
Articles
Redefining interoperability in the digital age
From Amazon pharmacy to Apple Health to Epic and Cerner battles to digital drug companions, the state of healthcare interoperability has come alive with digital power. And the COVID-19 pandemic accelerated this ability making telehealth mainstream for most medical...
Articles
Applying Agile methodologies in CDMOs
In order to truly help biotech and pharmaceutical companies in their journey from drug development to commercialization, contract development and manufacturing organisations (CDMOs) have begun to incorporate the latest innovations in all aspects of their operations. Whether this implementation...
Articles
Cracking the code for viral vector success
The virotherapy market is a fascinating and fast-paced environment to be in at the moment. From cutting-edge vaccination technologies, to targeted immuno-oncology therapies and potentially curative in-vivo gene therapies, innovation is occurring rapidly and driven by companies ranging from...
Articles
Adding Another Dimension to Protein Analysis
How an emerging mass spectrometry technique – TIMS – is revolutionising shotgun proteomics.
High-performance liquid chromatography with time-of-flight mass spectrometry (HPLC–TOFMS) has become a powerful technology for identifying and quantifying proteins. Having said that, it’s still very challenging to achieve...
Articles
Meeting Future Global Healthcare Needs with Manufacturing 4.0
The COVID-19 pandemic has brought unprecedented attention to the speed at which drugs are developed, tested, manufactured, and distributed. The need for vaccines and effective treatments for Sars-CoV-2 has meant that the pharmaceutical industry has had to move faster...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.